ID: ALA5286019

Max Phase: Preclinical

Molecular Formula: C7H9N

Molecular Weight: 107.16

Associated Items:

Representations

Canonical SMILES:  Cc1ccnc(C)c1

Standard InChI:  InChI=1S/C7H9N/c1-6-3-4-8-7(2)5-6/h3-5H,1-2H3

Standard InChI Key:  JYYNAJVZFGKDEQ-UHFFFAOYSA-N

Associated Targets(Human)

UHRF1 Tbio E3 ubiquitin-protein ligase UHRF1 (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 107.16Molecular Weight (Monoisotopic): 107.0735AlogP: 1.70#Rotatable Bonds: 0
Polar Surface Area: 12.89Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.58CX LogP: 1.40CX LogD: 1.34
Aromatic Rings: 1Heavy Atoms: 8QED Weighted: 0.49Np Likeness Score: -1.23

References

1. Vaidergorn MM, da Silva Emery F, Ganesan A..  (2021)  From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD).,  64  (19.0): [PMID:34591474] [10.1021/acs.jmedchem.1c00787]

Source